TG-1801
TG-1801-102
Phase 1 mab terminated
Quick answer
TG-1801 for CLL is a Phase 1 program (mab) at TG THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TG THERAPEUTICS, INC.
- Indication
- CLL
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated